Siemens Healthcare Diagnostics, Inc.: Device Recall

Recall #Z-0366-2026 · 09/22/2025

Class II: Risk

Recall Details

Recall Number
Z-0366-2026
Classification
Class II
Product Type
Device
Recalling Firm
Siemens Healthcare Diagnostics, Inc.
Status
Ongoing
Date Initiated
09/22/2025
Location
East Walpole, MA, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1740 units (61 US, 1679 OUS)

Reason for Recall

The potential for falsely depressed Intact PTH patient results at the low end of the assay range, less than or equal to 50 pg/mL (less than or equal to 5.3 pmol/L), when using specific lots identified by the firm on the IMMULITE 2000/IMMULITE 2000 XPi systems. The bias is observed in both serum and plasma samples.

Product Description

Assay: IMMULITE 2000 Intact PTH; Test Code: iPT; Siemens Material Number (SMN): (1) 10381441, (2) 10381442; Catalog Number: (1) L2KPP2, (2) L2KPP6;

Distribution Pattern

Worldwide - US Nationwide distribution in the states of AL, CA, DC, FL, ID, IN, LA, MD, NC, NJ, NY, PA, SC and the countries of Argentina, Australia, Bolivia, Bosnia Herzeg, Brazil, Bulgaria, Canada, Chile, Colombia, Cyprus, Czech Republic, Ecuador, Egypt, France, Germany, Greece, Guatemala, Honduras, Hungary, India, Iran, Israel, Italy, Kosovo, Kuwait, Latvia, Lebanon, Macedonia, Mexico, Nepal, Netherlands, P.R. China, Pakistan, Palestinian Ter, Paraguay, Peru, Poland, Portugal, Qatar, Romania, Russian Fed., Serbia, Slovakia, Slovenia, South Africa, Spain, Taiwan, Tunisia, Turkey, Turkmenistan, U.A.E., Ukraine, Uruguay, Uzbekistan.

Other Recalls by Siemens Healthcare Diagnostics, Inc.

View all recalls by Siemens Healthcare Diagnostics, Inc. →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.